Transcranial Electrical Stimulation for Chronic Post-Mastectomy Pain Syndrome: Analgesic Effect and Changes in Cortisol and β-Endorphin Levels

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Chronic post-mastectomy pain syndrome (CPMPS) affects 20%–50% of patients and significantly impairs quality of life. Venlafaxine is commonly used as part of comprehensive rehabilitation; however, side effects limit its efficacy. Transcranial electrical stimulation (TES) is being considered as a potential alternative.

AIM: The work aimed to assess the efficacy of transcranial electrical stimulation as an alternative to venlafaxine in reducing pain and improving plasma cortisol and β-endorphin levels in patients with CPMPS within the recommended comprehensive rehabilitation algorithm.

MATERIALS AND METHODS: The study included 90 outpatients with CPMPS randomized into two groups: the treatment group (n=45), in which TES was used instead of venlafaxine within the recommended comprehensive rehabilitation algorithm, and the comparison group (n=45), which received the recommended algorithm. Efficacy was assessed after 56 days using visual analog scale pain scores and plasma cortisol and β-endorphin levels. The control group included 80 individuals without CPMPS.

RESULTS: After 56 days of comprehensive rehabilitation, significant intergroup differences were found in the number of patients who achieved complete pain relief (p=0.017), as well as in cortisol levels (p = 0.001) and β-endorphin levels (p < 0.001).

CONCLUSIONS: The findings support the use of TES as an effective and safe alternative to antidepressant pharmacotherapy in the comprehensive rehabilitation of patients with CPMPS.

Full Text

Restricted Access

About the authors

Kirill A. Strоkov

Crimean Republican Oncological Clinical Dispensary named after V.M. Efetov

Author for correspondence.
Email: strokovk@mail.ru
ORCID iD: 0009-0003-3061-293X
Russian Federation, Simferopol

References

  1. Plinsinga ML, Singh B, Rose GL, et al. The Effect of Exercise on Pain in People with Cancer: A Systematic Review with Meta-analysis. Sports Med. 2023;53(9):1737–1752. doi: 10.1007/s40279-023-01862-9
  2. Tait RC, Zoberi K, Ferguson M, et al. Herndon C. Persistent Post-Mastectomy Pain: Risk Factors and Current Approaches to Treatment. J Pain. 2018;19(12):1367–1383. doi: 10.1016/j.jpain.2018.06.002
  3. Calapai M, Puzzo L, Bova G, et al. Effects of Physical Exercise and Motor Activity on Depression and Anxiety in Post-Mastectomy Pain Syndrome. Life. 2024;14:77. doi: 10.3390/life14010077
  4. Veening JG, Barendregt HP. The effects of beta-endorphin: state change modification. Fluids Barriers CNS. 2015;12:3. doi: 10.1186/2045-8118-12-3
  5. Ramírez-Expósito MJ, Dueñas-Rodríguez B, Carrera-González MP, Navarro-Cecilia J, Martínez-Martos JM. Circulating levels of β-endorphin and cortisol in breast cancer. Compr Psychoneuroendocrinol. 2021;23(5):100028. doi: 10.1016/j.cpnec.2021.100028
  6. Calapai M, Esposito E, Puzzo L, et al. Post-Mastectomy Pain: An Updated Overview on Risk Factors, Predictors, and Markers. Life (Basel). 2021;11(10):1026. doi: 10.3390/life11101026
  7. Leonard TM, Klem SA, Asher MA, Rapoff MA, Leff RD. Relationship between pain severity and serum beta-endorphin levels in postoperated patients. Pharmacotherapy. 1993;13:378–381.
  8. Thornton LM, Andersen BL, Blakely WP. The pain, depression, and fatigue symptom cluster in advanced breast cancer: Covariation with the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. Health Psychol. 2010;29:333–337. doi: 10.1037/a0018836
  9. Grushina TI, Zhavoronkova VV, Tkachenko GA, Kovalenko NV, Lysenko MA. A guide for doctors on the rehabilitation of breast cancer patients. Journal of Modern Oncology. 2020;22(3):3–34. doi: 10.26442/18151434.2020.3.200404 EDN: AMTYTP
  10. Davydov OS, Jahno NN, Kukushkin ML, et al. Neuropathic pain: clinical guidelines on the diagnostics and treatment from the russian association for the studying of pain. Russian Journal of Pain. 2018;58(4):5–41. EDN: VOUACX
  11. Kus T, Aktas G, Alpak G, et al. Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: a single-center retrospective case-control study. Support Care Cancer. 2016;24(5):2085–2091. doi: 10.1007/s00520-015-3009-x
  12. Lebedev VP. Transcranial electroanalgesia. In: Mikhailovich VA, Ignatov YuD, editors. Pain syndrome. Leningrad; 1990: 162–172. (In Russ.).
  13. Derry S, Cording M, Wiffen PJ, et al. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2016;2016(9):CD011790. doi: 10.1002/14651858.CD011790.pub2
  14. Pedraz-Petrozzi B, Sardinha H, Gilles M, Deuschle M. Effects of left anodal transcranial direct current stimulation on hypothalamic-pituitary-adrenal axis activity in depression: a randomized controlled pilot trial. Sci Rep. 2023; 6;13(1):5619. doi: 10.1038/s41598-023-32531-6.
  15. Hannibal KE, Bishop MD. Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation. Phys Ther. 2014;94(12):1816–25. doi: 10.2522/ptj.20130597
  16. Gabis L, Shklar B, Geva D. Immediate influence of transcranial electrostimulation on pain and beta-endorphin blood levels: an active placebo-controlled study. Am J Phys Med Rehabil. 2003;82(2):81–5. doi: 10.1097/00002060-200302000-00001
  17. Khedr EM, Omran EAH, Ismail NM, et al. Effects of transcranial direct current stimulation on pain, mood and serum endorphin level in the treatment of fibromyalgia: A double blinded, randomized clinical trial. Brain Stimul. 2017;10(5):893–901. doi: 10.1016/j.brs.2017.06.006.
  18. Moshfeghinia R, Shekouh D, Mostafavi S, et al. The effects of transcranial direct-current stimulation (tDCS) on pain intensity of patients with fibromyalgia: a systematic review and meta-analysis. BMC Neurol. 2023; 23(1):395. doi: 10.1186/s12883-023-03445-7

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86508 от 11.12.2023. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80650 от 15.03.2021 г.